IL2 and B-cell non-Hodgkin lymphoma: In this context, we previously demonstrated using A20luc/YFP cells (murine B cell lymphoma) that transplanting donor TL1A-Ig + IL-2 spleen cells (containing ~4 × 105 Tregs) GVHD was significantly reduced and GVL was preserved (7).